Clinical Aspects of O+G Flashcards
What form of imaging is predominantly used in O+G?
US
Evaluate the different imaging modalities which may be used in pregnancy.
• X-Ray
- Away from pelvis, negligible
- Avoid radiation of breast tissue and uterus
• MR
- No evidence of harm
• CT (+ CTPA)
- Increased risk (10%) of breast cancer
- Relative risk is 1.1x
• V:Q Scan
- No established risk
- Lower sensitivity and specificity cf CTPA
• US
- No direct harm
- False positive risks e.g. ovarian cysts of unknown significance anxiety or unnecessary intervention
State 3 things which may be looked for when ultrasound scanning the uterus.
• Uterine anomalies – bicornuate uterus
• Uterine tumours – fibroids
• Cervix – length predictor for onset of labour
- Important if premature/late miscarriage
• Uterine artery blood supply – predictor for pre-eclampsia
State 5 things a healthcare worker may be looking for when imaging a foetus with ultrasound.
- ‘Alive’ or not
- Location: IU/Ectopic
- Size of foetus (Crown-Rump Length – CRL)
- Number of foetuses and type
- Anatomical structures
• Foetal anomaly screening (18-21 weeks): head/cerebral hemispheres/lateral ventricles/cerebellum/foetal face/limbs/hands/feet/diaphragm/kidneys and bladder/spine
• Growth: Abdominal and head circumference/femur length + Estimated foetal weight
• Wellbeing: Liquor volume and Foetal blood flow measurements (blood flow; absent flow in diastole ≈ high placental resistance)
- Can check Middle Cerebral Artery (foetal anaemia or hypoxia) or Ductus Venosus (reversal of wave form in pre-terminal hypoxia)
• Presentation (cephalic vs breech or transverse vs oblique)
• Position of head in labour (e.g. if occiputs transverse before using forceps)
Describe antenatal care.
Medical care provided to detect and manage pre-existing maternal/foetal disorders that may affect the pregnancy or foetal wellbeing.
Outline what is done at an antenatal booking visit.
- Full history, full examination
- Fundal height should be taken (cm)
- Blood tests: ABO, Rhesus, STI screening, HBV, HCV, ßhCG and PAPP-A
- Early pregnancy US scan: viability, number of foetuses, gestation, nuchal translucency
Which blood tests are conducted at the booking visit?
• Blood tests: ABO, Rhesus, STI screening, HBV, HCV, ßhCG and PAPP-A
What does the early pregnancy scan look at?
viability, number of foetuses, gestation, nuchal translucency
When is the booking visit scheduled for?
12/40
Upon follow-up visits, what is conducted?
- Full history, full examination
- Fundal height should be taken (cm), Liqor volume, foetal lie, presentation, foetal HR
- Mid-pregnancy scan (20 weeks): microencephaly, short limbs, brain anomalies, cardiac anomalies; placental position
- Quadruple blood tests: ßhCG, AFP, inhibin-A, unconjugated estriol (uE3)
When is the Quadruple test scheduled for?
around 20 weeks
What does the Quadruple test assess?
uE3
AFP
ßhCG
Inhibin-A
When is the mid-pregnancy scan indicated?
• Mid-pregnancy scan (20 weeks): microencephaly, short limbs, brain anomalies, cardiac anomalies; placental position
What does the mid-pregnancy scan look for?
microencephaly, short limbs, brain anomalies, cardiac anomalies; placental position
Most are seen after 20 weeks however cardiac abnormalities are seen after 12 weeks
What is the risk threshold for investigating the risk of Down Syndrome in a foetus.
1 in 250
Describe CVS and the risks.
= Removal of chorionic villi cells from placenta to genetically analyse (12 weeks onwards)
- Miscarriage rate of 2% (2/100)
Describe Amniocentesis and the risks.
Removal of amniotic fluid from the uterus to genetically analyse cells (15 weeks onwards)
- Miscarriage rate of 1% (1/100)
Describe pre-implantation genetic diagnosis.
Genetic test using FISH on embryo prior to re-implanting. This requires ART such as IVF.
Evaluate the benefits and drawbacks of PIGD.
Benefits:
- Assurance
- Less likely to require TOP
Drawbacks:
- Invasive
- Costly
- Risk of multiparity
State the indications for PIGD.
- Parental chromosomal abnormality
- Robertsonian translocation
- Reciprocal translocation
- X-linked disorders
- Genetic disorders
List 3 principles of safe prescribing in pregnancy
- Establish exposure to medication: exposure; gestational age; PMHx; FHx; Check drug information; Background risk
- Intended continuation/initiation of medication: Benefits > costs; try to avoid 1/3 use; Use drugs known in pregnancy; Absence of data ≠ safety
- ICE and pre-conception planning/first consultation/background screening + check
List 3 drugs you should not prescribe when breastfeeding.
MTX Cyclophosphamide Lithium Metronidazole Chloramphenicol Aminoglycosie